Howard Hughes Medical Institute’s Corpay CPAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15
Closed -$4.51K 495
2025
Q4
$4.51K Hold
15
﹤0.01% 363
2025
Q3
$4.32K Hold
15
﹤0.01% 370
2025
Q2
$4.98K Buy
+15
New +$4.89K ﹤0.01% 333
2017
Q1
Sell
-20,000
Closed -$2.83M 167
2016
Q4
$2.83M Sell
20,000
-15,000
-43% -$2.35M 0.65% 40
2016
Q3
$6.08M Hold
35,000
1.57% 21
2016
Q2
$5.01M Hold
35,000
1.68% 19
2016
Q1
$5.21M Buy
+35,000
New +$4.55M 1.15% 20
2014
Q2
Sell
-1,718
Closed -$198K 243
2014
Q1
$198K Buy
1,718
+26
+2% +$3.03K 0.03% 87
2013
Q4
$198K Sell
1,692
-235
-12% -$27K 0.03% 89
2013
Q3
$212K Buy
+1,927
New +$188K 0.03% 79

Other funds holding CPAY

Howard Hughes Medical Institute's CPAY Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Corpay (CPAY) in Q1 2026, closing a stake of 15 shares — an estimated $4.51K sold.

Howard Hughes Medical Institute first reported a position in CPAY in Q3 2013 and held it in 10 quarters. The position peaked at $6.08M in Q3 2016. 682 funds tracked by Wall St. Rank hold CPAY as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Corpay position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 15 Corpay shares in Q1 2026, an estimated $4.51K.
  • Howard Hughes Medical Institute first reported a position in Corpay in Q3 2013 and held it in 10 quarters.
  • Howard Hughes Medical Institute's Corpay position peaked at $6.08M in Q3 2016.
  • 682 funds tracked by Wall St. Rank held Corpay as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.